T 100 (Tarceva 100 mg)

Generic Name: erlotinib

Pill imprint T 100 has been identified as Tarceva 100 mg.

Tarceva is used in the treatment of non-small cell lung cancer; pancreatic cancer; renal cell carcinoma and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Tarceva 100 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for T 100

Tarceva 100 mg T 100
Tarceva
Generic Name:
erlotinib
Imprint:
T 100
Strength:
100 mg
Color:
White
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
EGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Genentech
National Drug Code (NDC):
50242-0063
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5474 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)